These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17312403)

  • 1. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
    Simon JK; Pasetti MF; Viret JF; Mischler R; Muñoz A; Lagos R; Levine MM; Campbell JD
    Hum Vaccin; 2007; 3(2):54-8. PubMed ID: 17312403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
    Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF
    Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.
    Reisinger EC; Tschismarov R; Beubler E; Wiedermann U; Firbas C; Loebermann M; Pfeiffer A; Muellner M; Tauber E; Ramsauer K
    Lancet; 2019 Dec; 392(10165):2718-2727. PubMed ID: 30409443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A trial of the intranasal vaccination of adults against measles: the approaches to an alternative revaccination method].
    Liashenko VA; Iuminova NV; Krasnova VP
    Vopr Virusol; 1992; 37(2):107-9. PubMed ID: 1441428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
    Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
    J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled Phase I clinical trial.
    ; Cape S; Chaudhari A; Vaidya V; Mulay R; Agarkhedkar S; Shermer C; Collins M; Anderson R; Agarkhedkar S; Kulkarni PS; Winston S; Sievers R; Dhere RM; Gunale B; Powell K; Rota PA; Papania M
    Vaccine; 2014 Nov; 32(50):6791-7. PubMed ID: 25446830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.
    Chandwani S; Beeler J; Li H; Audet S; Smith B; Moye J; Nalin D; Krasinski K;
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S179-89. PubMed ID: 21666159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
    Zhang SJ; Xiao QY; Li FJ
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
    Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
    Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.
    Yee JL; ; McChesney MB; Christe KL
    Comp Med; 2015 Oct; 65(5):448-54. PubMed ID: 26473350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
    Liashenko VA; Krasnova VP; Youminova NV
    Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
    LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis.
    Low N; Kraemer S; Schneider M; Restrepo AM
    Vaccine; 2008 Jan; 26(3):383-98. PubMed ID: 18082295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
    Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka.
    Wijesinghe PR; Abeysinghe MR; Yoksan S; Yao Y; Zhou B; Zhang L; Yaich M; Neuzil KM; Victor JC
    Vaccine; 2014 Aug; 32(37):4751-7. PubMed ID: 24951871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.